Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
In 1995, a warning was issued by the Committee on the Safety of
Medicines advising that third generation oral contraceptives should not
be used in women with risk factors for venous thromboembolism, such as
obesity. However, a study published in the BMJ based on data
from the General Practice Research Database concluded that the risk of
venous thromboembolism with third generation oral contraceptives
was not greater than that with oral contraceptives containing
levonorgestrel. On p 1190 Jick et al show that the twofold risk of
idiopathic venous thromboembolism associated with third generation
oral contraceptives existed both before and after the warning.